Chinoline und Chinazoline Verbindungen und ihre therapeutische Anwendung

Compounds of formula I, wherein R represents C1-4 alkoxy optionally substituted by one or more fluorine atoms, R represents an aryl group or a heteroaryl group, optionally substituted by C1-4 alkyl or SO2NH2; R represents a 4-, 5-, 6-, or 7-membered heterocyclic ring containing at least one heteroat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	COLLIS, ALAN JOHN, FOX, DAVID NATHAN ABRAHAM
Format:	Patent
Sprache:	ger
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	COLLIS, ALAN JOHN FOX, DAVID NATHAN ABRAHAM
description	Compounds of formula I, wherein R represents C1-4 alkoxy optionally substituted by one or more fluorine atoms, R represents an aryl group or a heteroaryl group, optionally substituted by C1-4 alkyl or SO2NH2; R represents a 4-, 5-, 6-, or 7-membered heterocyclic ring containing at least one heteroatom selected from N, O and S, the ring being optionally fused to a benzene ring or a 5- or 6-membered heterocyclic ring containing at least one heteroatom selected from N, O and S, the ring system as a whole being optionally substituted, X represents CH or N; and L is absent, or represents a cyclic group of formula Ia, or represents a chain of formula Ib, and pharmaceutically acceptable salts thereof, are useful in the treatment of a variety of disorders including benign prostatic hyperplasia.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DE69811556TT2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DE69811556TT2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DE69811556TT23</originalsourceid><addsrcrecordid>eNrjZPBwzsjMy8_JzEtVKM1LUQDxEqsg_LDUoqTMvJTSvPTUPLBkZkZRqkJJRmpRYkFqaUlmcXJGqoJjXnkqWA0PA2taYk5xKi-U5mZQcnMNcfbQTS3Ij08tLkhMTs1LLYl3cTWztDA0NDU1CwkxMiZKEQBFmDWU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Chinoline und Chinazoline Verbindungen und ihre therapeutische Anwendung</title><source>esp@cenet</source><creator>COLLIS, ALAN JOHN ; FOX, DAVID NATHAN ABRAHAM</creator><creatorcontrib>COLLIS, ALAN JOHN ; FOX, DAVID NATHAN ABRAHAM</creatorcontrib><description>Compounds of formula I, wherein R represents C1-4 alkoxy optionally substituted by one or more fluorine atoms, R represents an aryl group or a heteroaryl group, optionally substituted by C1-4 alkyl or SO2NH2; R represents a 4-, 5-, 6-, or 7-membered heterocyclic ring containing at least one heteroatom selected from N, O and S, the ring being optionally fused to a benzene ring or a 5- or 6-membered heterocyclic ring containing at least one heteroatom selected from N, O and S, the ring system as a whole being optionally substituted, X represents CH or N; and L is absent, or represents a cyclic group of formula Ia, or represents a chain of formula Ib, and pharmaceutically acceptable salts thereof, are useful in the treatment of a variety of disorders including benign prostatic hyperplasia.</description><edition>7</edition><language>ger</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030828&DB=EPODOC&CC=DE&NR=69811556T2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030828&DB=EPODOC&CC=DE&NR=69811556T2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>COLLIS, ALAN JOHN</creatorcontrib><creatorcontrib>FOX, DAVID NATHAN ABRAHAM</creatorcontrib><title>Chinoline und Chinazoline Verbindungen und ihre therapeutische Anwendung</title><description>Compounds of formula I, wherein R represents C1-4 alkoxy optionally substituted by one or more fluorine atoms, R represents an aryl group or a heteroaryl group, optionally substituted by C1-4 alkyl or SO2NH2; R represents a 4-, 5-, 6-, or 7-membered heterocyclic ring containing at least one heteroatom selected from N, O and S, the ring being optionally fused to a benzene ring or a 5- or 6-membered heterocyclic ring containing at least one heteroatom selected from N, O and S, the ring system as a whole being optionally substituted, X represents CH or N; and L is absent, or represents a cyclic group of formula Ia, or represents a chain of formula Ib, and pharmaceutically acceptable salts thereof, are useful in the treatment of a variety of disorders including benign prostatic hyperplasia.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPBwzsjMy8_JzEtVKM1LUQDxEqsg_LDUoqTMvJTSvPTUPLBkZkZRqkJJRmpRYkFqaUlmcXJGqoJjXnkqWA0PA2taYk5xKi-U5mZQcnMNcfbQTS3Ij08tLkhMTs1LLYl3cTWztDA0NDU1CwkxMiZKEQBFmDWU</recordid><startdate>20030828</startdate><enddate>20030828</enddate><creator>COLLIS, ALAN JOHN</creator><creator>FOX, DAVID NATHAN ABRAHAM</creator><scope>EVB</scope></search><sort><creationdate>20030828</creationdate><title>Chinoline und Chinazoline Verbindungen und ihre therapeutische Anwendung</title><author>COLLIS, ALAN JOHN ; FOX, DAVID NATHAN ABRAHAM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DE69811556TT23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>2003</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>COLLIS, ALAN JOHN</creatorcontrib><creatorcontrib>FOX, DAVID NATHAN ABRAHAM</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>COLLIS, ALAN JOHN</au><au>FOX, DAVID NATHAN ABRAHAM</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Chinoline und Chinazoline Verbindungen und ihre therapeutische Anwendung</title><date>2003-08-28</date><risdate>2003</risdate><abstract>Compounds of formula I, wherein R represents C1-4 alkoxy optionally substituted by one or more fluorine atoms, R represents an aryl group or a heteroaryl group, optionally substituted by C1-4 alkyl or SO2NH2; R represents a 4-, 5-, 6-, or 7-membered heterocyclic ring containing at least one heteroatom selected from N, O and S, the ring being optionally fused to a benzene ring or a 5- or 6-membered heterocyclic ring containing at least one heteroatom selected from N, O and S, the ring system as a whole being optionally substituted, X represents CH or N; and L is absent, or represents a cyclic group of formula Ia, or represents a chain of formula Ib, and pharmaceutically acceptable salts thereof, are useful in the treatment of a variety of disorders including benign prostatic hyperplasia.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	ger
recordid	cdi_epo_espacenet_DE69811556TT2
source	esp@cenet
subjects	ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	Chinoline und Chinazoline Verbindungen und ihre therapeutische Anwendung
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T14%3A26%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=COLLIS,%20ALAN%20JOHN&rft.date=2003-08-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDE69811556TT2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true